Syon Capital’s Nuvalent NUVL Stock Holding History

Syon Capital’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,243	Closed	-$254K	–	639
2024 Q4	$254K	Buy	+3,243	New	+$303K	0.02%	451

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Syon Capital's NUVL Position: Q1 2025 in Review

Syon Capital sold out of Nuvalent (NUVL) in Q1 2025, closing a stake of 3,243 shares — an estimated $254K sold.

Syon Capital first reported a position in NUVL in Q4 2024 and held it in 1 quarter. The position peaked at $254K in Q4 2024. 205 funds tracked by Wall St. Rank hold NUVL as of Q1 2025.

Syon Capital reported no remaining Nuvalent position as of Q1 2025 after selling out during the quarter.
Syon Capital sold 3,243 Nuvalent shares in Q1 2025, an estimated $254K.
Syon Capital first reported a position in Nuvalent in Q4 2024 and held it in 1 quarter.
Syon Capital's Nuvalent position peaked at $254K in Q4 2024.
205 funds tracked by Wall St. Rank held Nuvalent as of Q1 2025.

Based on Syon Capital's 13F filing for Q1 2025, filed 15 May 2025.